Lemaitre Vascular Inc. | Small-cap | Healthcare
$87.49
-0.41%
| Lemaitre Vascular Stock Comparison:
Lemaitre Vascular vs Intuitive SurgicalLemaitre Vascular vs Becton, DickinsonLemaitre Vascular vs AtriCureLemaitre Vascular vs AzentaLemaitre Vascular vs Anbio BiotechnologyLemaitre Vascular vs S&P 500 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 59.9M
Gross Profit 41.4M 69.18%
Operating Income 12.6M 21.09%
Net Income 11.0M 18.39%
EPS (Diluted) $0.48

Balance Sheet Metrics

Total Assets 556.0M
Total Liabilities 208.4M
Shareholders Equity 347.6M
Debt to Equity 0.60

Cash Flow Metrics

Operating Cash Flow 5.7M
Free Cash Flow 7.7M

Revenue & Profitability Trend

Lemaitre Vascular Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i219.9M193.5M161.7M154.4M129.4M
Cost of Goods Sold i69.0M66.4M56.8M53.0M44.7M
Gross Profit i150.9M127.0M104.9M101.4M84.6M
Gross Margin % i68.6%65.7%64.9%65.7%65.4%
Operating Expenses
Research & Development i15.6M17.0M13.3M11.8M10.1M
Selling, General & Administrative i83.0M72.9M61.7M53.2M46.2M
Other Operating Expenses i-----
Total Operating Expenses i98.6M89.9M75.0M65.0M56.3M
Operating Income i52.3M37.2M29.9M36.4M28.3M
Operating Margin % i23.8%19.2%18.5%23.6%21.9%
Non-Operating Items
Interest Income i4.9M3.1M986.0K197.0K207.0K
Interest Expense i205.0K002.2M1.3M
Other Non-Operating Income-125.0K-799.0K-3.4M-116.0K141.0K
Pre-tax Income i56.9M39.5M27.5M34.3M27.4M
Income Tax i12.8M9.4M6.9M7.4M6.1M
Effective Tax Rate % i22.6%23.7%24.9%21.5%22.4%
Net Income i44.0M30.1M20.6M26.9M21.2M
Net Margin % i20.0%15.6%12.8%17.4%16.4%
Key Metrics
EBITDA i66.8M49.5M40.0M47.6M36.6M
EPS (Basic) i$1.96$1.36$0.94$1.27$1.05
EPS (Diluted) i$1.93$1.34$0.93$1.25$1.04
Basic Shares Outstanding i2245200022217000219750002115700020246000
Diluted Shares Outstanding i2245200022217000219750002115700020246000

Income Statement Trend

Lemaitre Vascular Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i25.6M24.3M19.1M13.9M26.8M
Short-term Investments i274.1M80.8M63.6M56.1M214.0K
Accounts Receivable i30.1M25.1M22.0M19.6M19.6M
Inventory i55.9M52.3M45.3M40.6M39.2M
Other Current Assets7.5M6.4M6.7M4.2M2.6M
Total Current Assets i402.2M194.6M161.7M139.9M94.3M
Non-Current Assets
Property, Plant & Equipment i42.0M39.0M30.9M31.0M28.9M
Goodwill i167.7M173.6M178.4M184.6M190.8M
Intangible Assets i35.8M41.7M46.5M52.7M58.9M
Long-term Investments-----
Other Non-Current Assets6.3M4.7M2.7M2.1M2.6M
Total Non-Current Assets i149.6M152.2M148.7M152.9M158.5M
Total Assets i551.8M346.8M310.5M292.8M252.8M
Liabilities
Current Liabilities
Accounts Payable i1.8M3.7M2.9M2.3M2.4M
Short-term Debt i2.7M2.5M1.9M1.9M4.5M
Current Portion of Long-term Debt-----
Other Current Liabilities1.4M24.0K573.0K1.3M772.0K
Total Current Liabilities i30.6M29.9M25.3M21.8M25.1M
Non-Current Liabilities
Long-term Debt i183.0M16.6M14.7M14.1M50.3M
Deferred Tax Liabilities i85.0K107.0K69.0K70.0K127.0K
Other Non-Current Liabilities259.0K1.6M1.5M1.9M3.8M
Total Non-Current Liabilities i183.9M19.0M16.9M16.8M55.1M
Total Liabilities i214.5M48.9M42.3M38.7M80.2M
Equity
Common Stock i242.0K239.0K237.0K235.0K221.0K
Retained Earnings i145.1M115.4M97.8M88.1M70.6M
Treasury Stock i15.6M13.9M13.0M12.4M11.6M
Other Equity-----
Total Shareholders Equity i337.3M297.9M268.2M254.2M172.6M
Key Metrics
Total Debt i185.7M19.1M16.6M15.9M54.8M
Working Capital i371.6M164.7M136.4M118.1M69.1M

Balance Sheet Composition

Lemaitre Vascular Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i44.0M30.1M20.6M26.9M21.2M
Depreciation & Amortization i9.7M9.5M9.4M11.1M8.4M
Stock-Based Compensation i6.6M5.3M4.2M3.5M3.0M
Working Capital Changes i-17.8M-8.3M-10.3M-8.0M774.0K
Operating Cash Flow i42.2M37.3M23.6M32.8M33.3M
Investing Activities
Capital Expenditures i-7.0M-7.3M-2.4M-4.9M-959.0K
Acquisitions i0-899.0K00-72.6M
Investment Purchases i-277.9M-16.6M-8.0M-59.2M-2.2M
Investment Sales i84.8M003.0M22.9M
Investing Cash Flow i-200.1M-24.7M-10.4M-61.1M-52.9M
Financing Activities
Share Repurchases i---642.0K-802.0K-570.0K
Dividends Paid i-14.4M-12.4M-11.0M-9.3M-7.7M
Debt Issuance i169.3M-0040.0M
Debt Repayment i-00-39.0M-26.0M
Financing Cash Flow i159.8M-6.3M-9.2M13.7M7.2M
Free Cash Flow i37.2M29.5M22.1M30.2M31.8M
Net Change in Cash i1.9M6.3M4.0M-14.6M-12.5M

Cash Flow Trend

Lemaitre Vascular Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 42.85
Forward P/E 40.48
Price to Book 5.48
Price to Sales 8.48
PEG Ratio 2.84

Profitability Ratios

Profit Margin 20.08%
Operating Margin 25.13%
Return on Equity 13.81%
Return on Assets 7.28%

Financial Health

Current Ratio 13.96
Debt to Equity 51.25
Beta 0.77

Per Share Data

EPS (TTM) $2.05
Book Value per Share $16.02
Revenue per Share $10.41

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
lmat2.0B42.855.4813.81%20.08%51.25
Intuitive Surgical 163.3B63.009.0816.04%28.51%0.00
Becton, Dickinson 55.7B35.462.186.18%7.41%75.93
AtriCure 1.8B-36.643.72-7.85%-7.27%16.63
Azenta 1.5B-9.010.89-9.15%-16.68%3.15
Anbio Biotechnology 1.4B643.2079.0214.83%28.99%0.00

Financial data is updated regularly. All figures are in the company's reporting currency.